SWAV Stock Forecast: Riding the Sonic Wave of Innovation in Cardiovascular Treatment

Anastasia MakuyevThis SWAV Stock Forecast article was written by Anastasia Makuyev – Quantitative Analyst at I Know First.


  • Shockwave Medical is innovating cardiovascular treatment with its Intravascular Lithotripsy (IVL) technology, which uses sonic pressure waves for minimally invasive procedures.
  • Recent financials showcase robust growth, with a YoY increase of 72% in Q1 2023 revenues and expectations of future growth, making it an appealing target for potential acquisitions.
  • Rumors of a takeover from giants like Johnson & Johnson and Medtronic have surfaced, yet irrespective of such speculations, Shockwave’s strong financial performance and differentiated technology make it a compelling investment.

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here